loading

Finanzdaten der 180 Life Sciences Corp-Aktie (ATNF)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
27.08%
1.7304
2.373 1.4064 0.9791 1.8467
Operating Income/Loss
27.08%
-1.7304
-2.373 -1.4064 -0.9791 -1.8467
Nonoperating Income/Loss
2.01%
0.00381
0.00374 -3.1631 0.1424 1.8585
Income/Loss From Continuing Operations Before Tax
27.12%
-1.7266
-2.3692 -4.5695 -0.8367 0.0118
Income/Loss From Continuing Operations After Tax
27.12%
-1.7266
-2.3692 -4.2735 -0.8367 0.0118
Net Income/Loss
27.12%
-1.7266
-2.3692 -4.2735 -0.8367 0.0118
Preferred Stock Dividends And Other Adjustments
-
- 8.0115 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
61.28%
5.7081
3.5393 0.0688 0.9806 0.9191
Diluted Average Shares
61.28%
5.7081
3.5393 0.0688 0.9806 0.9191
Basic Earnings Per Share
55.22%
-0.30
-0.67 -13.25 -0.85 0.01
Diluted Earnings Per Share
55.22%
-0.30
-0.67 -13.25 -0.85 0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 8.0115 - -
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):